Shenzhen Weiguang Biological Products Co., Ltd.

XSEC:002880 Stock Report

Market Cap: CN¥6.5b

Shenzhen Weiguang Biological Products Future Growth

Future criteria checks 1/6

Shenzhen Weiguang Biological Products is forecast to grow earnings and revenue by 13.8% and 11.8% per annum respectively. EPS is expected to grow by 13.5% per annum. Return on equity is forecast to be 12.4% in 3 years.

Key information

13.8%

Earnings growth rate

13.5%

EPS growth rate

Biotechs earnings growth43.3%
Revenue growth rate11.8%
Future return on equity12.4%
Analyst coverage

Low

Last updated02 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:002880 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,511337N/A4601
12/31/20251,347294N/A3501
12/31/20241,194255N/A2401
9/30/20241,167250-27283N/A
6/30/20241,114227-122251N/A
3/31/20241,06622035335N/A
12/31/20231,04921969398N/A
9/30/2023992196-85278N/A
6/30/2023893172-36239N/A
3/31/2023739138-28858N/A
1/1/2023668118-3261N/A
9/30/2022702141-18965N/A
6/30/2022803182-140188N/A
3/31/2022907204-40221N/A
1/1/20229072056247N/A
9/30/2021914207-37212N/A
6/30/2021833183-60154N/A
3/31/202185418649266N/A
12/31/2020905190115304N/A
9/30/2020895183123260N/A
6/30/2020868178224319N/A
3/31/2020842176186261N/A
12/31/2019821171108186N/A
9/30/2019753158131201N/A
6/30/2019749158110182N/A
3/31/201972615956131N/A
12/31/201868815715100N/A
9/30/2018651156-3154N/A
6/30/2018610148N/A-15N/A
3/31/2018606145N/A-15N/A
12/31/2017623155N/A29N/A
9/30/2017574144N/A39N/A
6/30/2017592154N/A79N/A
3/31/2017577154N/A115N/A
12/31/2016566153N/A126N/A
6/30/2016513132N/A142N/A
3/31/2016501125N/A121N/A
12/31/2015501125N/A150N/A
12/31/2014453101N/A134N/A
12/31/201335589N/A21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002880's forecast earnings growth (13.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 002880's earnings (13.8% per year) are forecast to grow slower than the CN market (26.3% per year).

High Growth Earnings: 002880's earnings are forecast to grow, but not significantly.

Revenue vs Market: 002880's revenue (11.8% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 002880's revenue (11.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002880's Return on Equity is forecast to be low in 3 years time (12.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y